La rigenerazione del miocardio nello scompenso cardiaco: ieri, oggi e domani

Il Diabete Pub Date : 2024-01-16 DOI:10.30682/ildia2304f
{"title":"La rigenerazione del miocardio nello scompenso cardiaco: ieri, oggi e domani","authors":"","doi":"10.30682/ildia2304f","DOIUrl":null,"url":null,"abstract":"Heart failure is the leading cause of death worldwide, due to the limited capacity of the adult heart to regenerate. Today, the treatment of heart failure is based on the use of devices, pharmacological therapy of symptoms, and heart transplantation. However, these approaches do not represent a long-term solution and the availability of heart donors is inadequate. For this reason, there is great interest in regenerative medicine to treat heart failure. This review summarizes primary strategies of cardiac regenerative medicine, their present status, and future perspectives and challenges.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"34 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Il Diabete","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30682/ildia2304f","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Heart failure is the leading cause of death worldwide, due to the limited capacity of the adult heart to regenerate. Today, the treatment of heart failure is based on the use of devices, pharmacological therapy of symptoms, and heart transplantation. However, these approaches do not represent a long-term solution and the availability of heart donors is inadequate. For this reason, there is great interest in regenerative medicine to treat heart failure. This review summarizes primary strategies of cardiac regenerative medicine, their present status, and future perspectives and challenges.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心力衰竭的心肌再生:昨天、今天和明天
由于成人心脏的再生能力有限,心力衰竭是导致全球死亡的主要原因。如今,治疗心力衰竭的方法主要是使用器械、对症药物治疗和心脏移植。然而,这些方法都不是长久之计,而且心脏捐献者的数量也不足。因此,人们对再生医学治疗心力衰竭产生了浓厚的兴趣。本综述总结了心脏再生医学的主要策略、现状以及未来的前景和挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ALIMENTI E PREVENZIONE DELLE MALATTIE CARDIOVASCOLARI I TRIGLICERIDI COME FATTORE DI RISCHIO CARDIOVASCOLARE LIPODISTROFIE: QUANDO MAGRO NON È SINONIMO DI METABOLICAMENTE SANO MEDICINA RIGENERATIVA E DIABETE DI TIPO 1: I PROGRESSI DELLA BIOINGEGNERIA APPLICATI ALLA SOSTITUZIONE DELLA FUNZIONE BETA-CELLULARE EFFETTI BENEFICI DI UN NUOVO COMPOSTO OMEGA-3
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1